Search Medicilon

Meet Medicilon at BioTrinity 2026

BioTrinity 2026

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Medicilon and Hailu Biotech of Yangtze River Pharmaceutical Group Forge Strategic Cooperation to Accelerate New Drug R&D and Global Outreach

Conjugation Chemistry In Vitro Activity Assessment

Oligonucleotide Therapeutics: Conjugation Chemistry & In Vitro Activity Assessment

Contact Medicilon

Name(Required)
Address(Required)